Medicine
More
-
May 2- Eli Lilly and Co:. *Boehringer ingelheim pharmaceuticals, inc. and Eli Lilly and Company launch. educational campaign about emerging science in type 2 diabetes.
-
DUBAI, May 2- Saudi Arabia said five more people have died of a deadly new virus from the same family as SARS, and two other people were in intensive care. The seven cases were discovered in al-Ahsa governorate in the Eastern Province, the Saudi news agency SPA quoted the Saudi Health Ministry as saying in a statement late on Wednesday.
-
BEIJING, May 2- A 55- year-old man in central China has died from a new strain of bird flu, bringing to 27 the number of deaths from the mysterious H7N9 virus, state news agency Xinhua said on Thursday. The H7N9 virus, which has infected 127 people in China, is a threat to world health and should be taken seriously, scientists said on Wednesday.
-
By Ransdell Pierson and Bill Berkrot. May 2- Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hepatitis C drugs appeared to have eliminated the liver virus after either eight weeks or 12 weeks of treatment in a small mid-stage study.
-
Lawyers with the Justice Department filed the appeal with the 2nd U.S. Circuit Court of Appeals in New York, according to court documents. District Judge Edward Korman's ruling from April 5 that required the FDA to make the emergency contraception available over-the-counter to women of all ages within 30 days.
-
Lawyers with the Justice Department filed the appeal with the 2nd U.S. Circuit Court of Appeals in New York, according to court documents. District Judge Edward Korman's ruling from April 5 that required the FDA to make the emergency contraception available over-the-counter to women of all ages within 30 days.
-
Lawyers with the Justice Department filed the appeal with the 2nd U.S. Circuit Court of Appeals in New York, according to court documents. District Judge Edward Korman's ruling from April 5 that required the FDA to make the emergency contraception available over-the-counter to women of all ages within 30 days.
-
LONDON, May 1- A new strain of bird flu that is causing a deadly outbreak among people in China is a threat to world health and should be taken seriously, scientists said on Wednesday. "The WHO considers this a serious threat," said John McCauley, director of the WHO Collaborating Centre for Influenza at Britain's National Institute for Medical Research.
-
CHICAGO, May 1- The first-ever drug designed to treat social impairments associated with autism failed to show a benefit in a midstage trial, representing a blow to families and to privately held drugmaker Seaside Therapeutics.
-
With five months until 2014 open enrollment starts, the picture's a little clearer in some of the 16 states that are building their own health exchange marketplaces, with CNBC's Bertha Coombs.
-
CHICAGO, May 1- The first-ever drug designed to treat social impairments associated with autism failed to show a benefit in a midstage trial, representing a blow to families and to privately held drugmaker Seaside Therapeutics.
-
May 1- Merck& Co Inc reported disappointing first-quarter sales on a surprising downturn for its Januvia diabetes medicine, the company's biggest product and usual earnings driver, and the drugmaker cut its profit forecast for the full year.
-
*Janssen research& development-daratumumab receives therapy designation in. double refractory multiple myeloma from FDA. *Source text for Eikon* Further company coverage ().
-
CHICAGO, May 1- The first-ever drug designed to treat social impairments associated with autism failed to show a benefit in a midstage trial, representing a blow to families and to privately held drugmaker Seaside Therapeutics.
-
The FDA said its approval was not related to the judge's ruling. Teva originally applied to sell Plan B to all females of reproductive age, but changed its latest bid to those 15 and older after 2011. The amended application was pending when Judge Edward Korman handed down his ruling, the FDA said.
-
Wall Street opened flat on Tuesday as investors awaited economic data and central bank meetings this week, looking for catalysts to push the benchmark S&P 500 index through 1,600. The Dow Jones industrial average dropped 0.11 percent. **APPLE INC, $434, up 1 pct.
-
Staff reviewers for the U.S. Food and Drug Administration are expected to ask a panel of medical experts on May 2 if another clinical trial is required before it approves an experimental kidney cancer drug made by Aveo Oncology and Astellas Pharma Inc. **MGIC INVESTMENT CORP, Monday close $5.48, down 13 pct premarket.
-
April 30- Transition Therapeutics Inc:. *Announces results of clinical study of type 2 diabetes drug candidate Tt-401. *TT-401 once-weekly administered peptide, demonstrated significant improvements.
-
*Analysts provide mixed interpretations of FDA review. April 30- Staff reviewers for the U.S. Food and Drug Administration have asked a panel of outside medical experts whether another clinical trial is needed before an experimental kidney cancer drug made by Aveo Pharmaceuticals Inc and Astellas Pharma Inc can be approved.
-
CHICAGO, April 29- An influential U.S. panel is calling for HIV screening for all Americans aged 15 to 65, regardless of whether they are considered to be at high risk, a change that may help lift some of the stigma associated with HIV testing.